Buta Warna

01Pathophysiology

Color vision is a function of the three cone photoreceptor classes in the retina, each containing a distinct opsin photopigment. L-cones absorb maximally near 564 nm (perceived as red), M-cones near 533 nm (green), and S-cones near 437 nm (blue). The brain compares relative activation across these three populations to construct color perception. When one cone class is missing (-opia) or functionally shifted (-omaly), the wavelength comparisons collapse and the patient confuses colors that lie along the affected axis.

The OPN1LW and OPN1MW genes sit adjacent to each other on the long arm of the X chromosome (Xq28). Because these two genes share over 96% sequence homology, unequal crossing over during meiosis frequently produces hybrid genes, deletions, or inactivating mutations. This explains why red-green color blindness follows an X-linked recessive pattern, affecting roughly 8% of males but only 0.5% of females. A classic vignette clue is an affected boy whose maternal grandfather or uncle had the same problem, since the carrier mother passes the abnormal X. The OPN1SW gene for blue cones is autosomal on chromosome 7, so isolated blue-yellow deficiency is rare and shows autosomal dominant inheritance.

In acquired color vision deficiency, damage to retinal or neural pathways selectively impairs color discrimination. Köllner's rule is a high-yield concept: outer retinal disease (such as age-related macular degeneration or central serous chorioretinopathy) tends to produce blue-yellow defects, whereas optic nerve disease (such as optic neuritis in multiple sclerosis or toxic optic neuropathy from ethambutol) tends to produce red-green defects. Glaucoma is the classic exception, often producing blue-yellow loss despite being a neural disease. Loss of red-green discrimination on a recently started ethambutol regimen is a near-pathognomonic test cue for early ocular toxicity, prompting drug discontinuation before vision loss progresses.

02Classification of Clinical Manifestations

A useful framework: anopia means the cone class is absent (dichromacy, more severe), while anomaly means the cone is present but shifted (anomalous trichromacy, milder). Deuteranomaly is the single most common congenital color vision deficiency worldwide and is the typical answer in a vignette describing a boy with mild red-green confusion.

03Diagnostic Workup

The workup begins with Ishihara plates as the best initial test because they are inexpensive, rapid, and highly sensitive for red-green deficiency, which accounts for the great majority of cases. The patient is asked to identify numerals embedded in dot patterns where the figure and background differ only in hue along the red-green axis. An individual with normal color vision sees the number; a deuteranope or protanope cannot distinguish it. Note that Ishihara plates are insensitive for blue-yellow defects, so HRR plates are preferred when tritan deficiency or acquired retinal disease is on the differential.

The anomaloscope is the most accurate confirmatory test and is considered the gold standard for red-green deficiency. The patient adjusts the proportion of red and green light to match a fixed yellow reference (the Rayleigh match). Protanopes accept matches with excessive red, while deuteranopes accept matches with excessive green, allowing precise classification. The Farnsworth-Munsell 100 hue test is used when grading severity matters, for example in occupational fitness assessments for pilots, mariners, or electricians; the patient arranges colored caps in chromatic order, and errors cluster along the deficient axis.

When the history suggests an acquired etiology (sudden onset, monocular involvement, associated visual loss, exposure to ethambutol or hydroxychloroquine, systemic disease), the workup expands to include fundoscopy, optical coherence tomography, visual fields, and review of medications. In a patient on long-term ethambutol with new red-green deficiency, the next best step is to stop the drug and refer to ophthalmology rather than to order further confirmatory testing.

04Management and Treatment

Congenital color vision deficiency has no curative treatment. Management centers on counseling, occupational guidance, and adaptive strategies. Parents should be reassured that intelligence, visual acuity, and ocular health are normal, and that the child can be taught to use brightness, position, and labels (for example, the position of traffic light bulbs) instead of hue. A carrier mother should be told that each son has a 50% chance of being affected and each daughter a 50% chance of being a carrier.

For acquired color vision deficiency, the priority is identifying and treating the cause. Ethambutol-induced optic neuropathy is the highest-yield example: any patient on this drug who develops red-green deficiency or decreased visual acuity should have the drug stopped immediately, with prompt ophthalmologic referral. Visual recovery is typically partial and depends on early discontinuation. Hydroxychloroquine toxicity classically produces a bull's eye maculopathy with blue-yellow loss and warrants annual screening with automated visual fields and spectral-domain OCT after five years of therapy or sooner in high-risk patients.

The next best step logic that often appears in question stems is: a child failed school vision screening; visual acuity is 20/20; what now? The answer is Ishihara plates, not formal ophthalmology referral, neuroimaging, or refraction. Conversely, a 35-year-old man with bilateral progressive central scotomas and red-green confusion is not a congenital case; the next best step is fundoscopy and review of medications and toxin exposures because this presentation suggests acquired optic neuropathy.

05Differential Diagnosis and Distractors

06Traps and High-Yield Pearls

The most common error is treating color blindness as a one-size-fits-all diagnosis and missing the distinction between congenital and acquired forms. Test writers exploit this in two recurring ways. First, they describe a young boy in a stable family pattern (often with an affected maternal uncle) and the trap is to over-investigate with neuroimaging or referral when the answer is simply Ishihara plates and reassurance with X-linked recessive counseling. Second, they describe an adult with new color vision changes, and the trap is to label this congenital; the actual task is to recognize acquired etiology and identify the causative drug or disease. Ethambutol is the highest-yield offender, and red-green dyschromatopsia is an early warning sign that should prompt immediate drug discontinuation, not dose adjustment or watchful waiting.

A second trap is mixing up the classification suffixes. Remember that -opia means absent (dichromacy) and -anomaly means shifted (anomalous trichromacy). Deuter refers to green (M-cone), prot refers to red (L-cone), and trit refers to blue (S-cone). Deuteranomaly is the most frequent congenital type and the safest default answer when a vignette describes mild red-green confusion in an otherwise healthy boy.

A third trap involves the gold standard question. Ishihara plates are the best initial screening test, but the anomaloscope is the most accurate confirmatory test for red-green deficiency. Confusing screening with confirmation is a common point of failure. Similarly, the Farnsworth-Munsell 100 hue test is the answer when the question asks about quantifying severity or occupational fitness rather than initial diagnosis.

The core competency being tested is recognizing a benign hereditary pattern in children (X-linked recessive red-green deficiency requiring counseling alone) while remaining alert for acquired color vision loss as a sentinel sign of treatable optic nerve, retinal, or drug-induced pathology in adults.